Birch-apple syndrome treated with birch pollen immunotherapy

International Archives of Allergy and Immunology

Volumn 156, Issue 4, 2011, Pages 416-422

  Mauro, Marina ^a   Russello, Marina ^a   Incorvaia, Cristoforo ^b   Gazzola, Gianbattista ^a   Frati, Franco ^c,d   Moingeon, Philippe ^f   Passalacqua, Gianni ^e  

^a SANT ANNA HOSPITAL   (Italy)

^b ICP Hospital   (Italy)

^c Medical and Scientific Department   (Italy)

^d UNIVERSITY OF PERUGIA   (Italy)

^e UNIVERSITY OF GENOA   (Italy)

^f Scientific Department   (France)

Author keywords

Apple; Apple challenge; Birch pollen; Birch apple syndrome; Mal d 1; Specific IgE; Subcutaneous immunotherapy; Sublingual immunotherapy

Indexed keywords

API G 1 ANTIGEN; BET V 1 ANTIGEN; DAU C 1 ANTIGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G4; MAL D 1 ANTIGEN; PLANT EXTRACT; POLLEN ANTIGEN; STALORAL; UNCLASSIFIED DRUG;

ADULT; ALLERGIC DISEASE; ALLERGY TEST; APPLE; ARTICLE; BIRCH; BIRCH APPLE SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOOD ALLERGY; HUMAN; IMMUNOLOGICAL TOLERANCE; MALE; ORAL ALLERGY SYNDROME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT ALLERGY; SUBCUTANEOUS IMMUNOTHERAPY; SUBLINGUAL IMMUNOTHERAPY; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ADMINISTRATION, SUBLINGUAL; ADOLESCENT; ADULT; ALLERGENS; BETULA; DESENSITIZATION, IMMUNOLOGIC; FEMALE; FOOD HYPERSENSITIVITY; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INJECTIONS, SUBCUTANEOUS; MALE; MALUS; MIDDLE AGED; POLLEN; SYNDROME; YOUNG ADULT;

EID: 81155158239     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000323909     Document Type: Article

References (36)

1. Pastorello EA, Ispano M, Pravettoni V, Farioli L, Incorvaia C, Ansaloni R, Ortolani C: Cross-reacting allergens in clinical syndromes. In Wuthrich B, Ortolani C (eds): Highlights in Food Allergy. Monogr Allergy, Basel, Karger, 1996; 32: 57-62.
2. Breiteneder H, Radauer C: A classification of plant food allergens. J Allergy Clin Immunol 2004; 113: 821-830. (Pubitemid 38608588)
3. Radauer C, Breiteneder H: Pollen allergens are restricted to few protein families and show distinct patterns of species distribution. J Allergy Clin Immunol 2006; 117: 141-147. (Pubitemid 43017151)
4. Aalberse RC: Assessment of allergen crossreactivity. Clin Mol Allergy 2007; 5: 2.
5. Ebner C, Birkner T, Valenta R, Rumpold H, Breitenbach M, Scheiner O, Kraft D: Common epitopes of birch pollen and apples. Studies by Western and Northern blot. J Allergy Clin Immunol 1991; 88: 588-594.
6. Bousquet J, Lockey RF, Malling HJ (eds): WHO Position Paper. Allergen immunotherapy: therapeutic vaccines for allergic diseases. Allergy 1998; 53(suppl 54):1-42.
7. Arvidsson MB, Lowhagen O, Rak S: Effect of 2-year placebo-controlled immunotherapy on airway symptoms and medications in patients with birch pollen allergy. J Allergy Clin Immunol 2002; 109: 777-783. (Pubitemid 34499509)
8. Bodtger U, Poulsen LK, Jacobi HH, Malling HJ: The safety and efficacy of subcutaneous birch pollen immunotherapy-a one-year, randomised, double-blind, placebo-controlled study. Allergy 2002; 57: 297-305. (Pubitemid 34280656)
9. Horak F, Stubner P, Berger UE, Marks B, Toth J, Jager S: Immunotherapy with sublingual birch pollen extract. A short-term double-blind placebo study. J Investig Allergol Clin Immunol 1998; 8: 165-171. (Pubitemid 28342473)
10. Voltolini S, Modena P, Minale P, Bignardi D, Troise C, Puccinelli P, et al: Sublingual immunotherapy in tree pollen allergy. Doubleblind, placebo-controlled study with a biologically standardized extract of three pollens (alder, birch and hazel) administered by a rush schedule. Allergol Immunopathol 2001; 29: 103-110.
11. Khinchi MS, Poulsen LK, Carat F, Andrè C, Hansen AB, Malling HJ: Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: a randomized, placebo-controlled, double blind, double dummy study. Allergy 2004; 59: 45-53. (Pubitemid 38167951)
12. Moller C: Effect of pollen immunotherapy on food hypersensitivity in children with birch pollinosis. Ann Allergy 1989; 62: 343-345. (Pubitemid 19116409)
13. Herrmann D, Henzgen M, Franck E: Rudeschko O, Jager L: Effect of hyposensitization for tree pollinosis on associated apple allergy. J Invest Allergol Clin Immunol 1995; 5: 259-267.
14. Asero R: Effects of birch pollen-specific immunotherapy on apple allergy in birch pollen-hypersensitive patients. Clin Exp Allergy 1998; 28: 1368-1373. (Pubitemid 28559011)
15. Modrzynski M, Zawiska E, Rapiejko P, Przybylski G: Specific-pollen immunotherapy in the treatment of oral allergy syndrome in patients with tree pollen hypersensitivity. Przegl Lek 2002; 59: 1007-1010.
16. Bucher X, Pichler WJ, Dahinden CA, Helbling A: Effect of tree pollen specific, subcutaneous immunotherapy on the oral allergy syndrome to apple and hazelnut. Allergy 2004; 59: 1272-1276. (Pubitemid 39506725)
17. Bolhaar ST, Tiemessen MM, Zuidmeer L, van Leeuwen A, Hoffmann- Sommergruber K, Bruijnzel-Koomen CA, et al: Efficacy of birch-pollen immunotherapy on cross-reactive food allergy confirmed by skin tests and double-blind food challenges. Clin Exp Allergy 2004; 34: 761-769. (Pubitemid 38736792)
18. Skamstrup Hansen K, Sondergaard Khinchi M, Stahl Skov P, Bindslev-Jensen C, Poulsen LK, Malling HJ: Food allergy to apple and specific immunotherapy with birch pollen. Mol Nutr Food Res 2004; 48: 441-448. (Pubitemid 39524531)
19. Kinaciyan T, Jahn-Schmid B, Radakovics A, Zwolfer B, Schreiber C, Francis JN, et al: Successful sublingual immunotherapy with birch pollen has limited effects on concomitant food allergy to apple and the immune response to the Bet v 1 homolog Mal d 1. J Allergy Clin Immunol 2007; 119: 937-943. (Pubitemid 46527803)
20. Niederberger V, Reisinger J, Valent P, Krauth MT, Pauli G, van Hage M, et al: Vaccination with genetically modified birch pollen allergens: immune and clinical effects on the oral allergy syndrome. J Allergy Clin Immunol 2007; 119: 1013-1016. (Pubitemid 46546426)
21. Czarnecka-Operacz M, Jenerowicz D, Silny W: Oral allergy syndrome in patients with airborne pollen allergy treated with specific immunotherapy. Acta Dermovenereol Croat 2008; 16: 19-24. (Pubitemid 351738196)
22. Bergmann KC, Wolf H, Schnitker J: Effect of pollen-specific sublingual immunotherapy on oral allergy syndrome. An observational study. WAO J 2008; 1: 79-84.
23. Mauro M, Russello M, Incorvaia C, Gazzola GB, Di Cara G, Frati F: Comparison of efficacy, safety and immunologic effects of subcutaneous and sublingual immunotherapy in birch pollinosis: a randomized study. Eur Ann Allergy Clin Immunol 2007; 39: 119-122. (Pubitemid 46732363)
24. Pastorello EA, Pravettoni V, Farioli L, Ispano M, Fortunato D, Monza M, et al: Clinical role of a lipid transfer protein that acts as a new apple-specific allergen. J Allergy Clin Immunol 1999; 104: 1099-106. (Pubitemid 29532136)
25. Deinhofer K, Sevcik H, Balic N, Harwanegg C, Hiller R, Rumpold H, et al: Microarrayed allergens for IgE profiling. Methods 2004; 32: 249-254. (Pubitemid 38201279)
26. Sampson HA: Food anaphylaxis. Br Med Bull 2000; 56: 925-935. (Pubitemid 32417160)
27. Leung DY, Sampson HA, Yunginger JW, Burks AW Jr, Schneider LC, Wortel CH, et al: Effect of anti-IgE therapy in patients with peanut allergy. N Engl J Med 2003; 348: 986-993. (Pubitemid 36302243)
28. Nelson HS, Lahr J, Rule R, Bock A, Leung D: Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract. J Allergy Clin Immunol 1997; 99: 744-751. (Pubitemid 27280363)
29. Enrique E, Pineda F, Malek T, Bartra J, Basagna M, Tella R, et al: Sublingual immunotherapy for hazelnut food allergy: a randomized double-blind, placebo-controlled study with a standardized hazelnut extract. J Allergy Clin Immunol 2005; 116: 1073-1079. (Pubitemid 41571791)
30. Fernandez-Rivas M, Garrido-Fernandez S, Nadal JA, Diaz de Durana MD, Garcia BE, Gonzalez-Mancebo E, et al: Randomized double-blind, placebo-controlled trial of sublingual immunotherapy with a Pru p 3 quantified peach extract. Allergy 2009; 64: 876-883.
31. Frew A: Sublingual immunotherapy. N Engl J Med 2008; 358: 2259-2264. (Pubitemid 351724455)
32. Aalberse RC: Assessment of allergen crossreactivity. Clin Mol Allergy 2007; 5: 2.
33. Son DY, Scheurer S, Hoffman A, Hausten D, Vieths S: Pollen-related food allergy: cloning and immunological analysis of isoforms and mutants of Mal d 1, the major apple allergen, and Bet v 1, the major birch pollen allergen. Eur J Nutr 1999; 38: 201-215. (Pubitemid 29454998)
34. Oberhuber C, Ma Y, MarsH J, Rigby N, Smole U, Radauer C, et al: Purification and characterisation of relevant natural and recombinant apple allergens. Mol Nutr Food Res 2008; 6: 1-12.
35. Sancho AI, van Ree R, van Leeuwen A, Meulenbroek BJ, van de Weg EW, Gilissen LJ, et al: Measurement of lipid transfer protein in 88 apple cultivars. Int Arch Allergy Immunol 2008; 146: 19-26.
36. Asero R: Effects of birch pollen SIT on apple allergy: a matter of dosage? Allergy 2004; 59: 1269-121.